22nd Century Group

22nd Century Group Net Margin

The Net Profit Margin of 22nd Century Group (XXII) as of Oct 28, 2026 is -71.70 %. In the previous year, Net Profit Margin was -127.66 % — a change of -43.84% (higher).

Net Margin

-71.70 %

YoY

-43.84%

Last updated:

Net Profit Margin of 22nd Century Group is 2025 -71.70 % . Net Profit Margin of 22nd Century Group was 2024 -127.66 % . It decreases by -43.84% higher compared to the previous year.

22nd Century Group's net margin stands at -71.7%, up from -105.4% several years earlier.

The 22nd Century Group Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
-30.15 USD
Jan 1, 2019
-102.81 USD
Jan 1, 2020
-70.12 USD
Jan 1, 2021
-105.37 USD
Jan 1, 2022
-147.65 USD
Jan 1, 2023
-437.14 USD
Jan 1, 2024
-127.66 USD
Jan 1, 2025
-71.70 USD
The 22nd Century Group Net Margin history
YEARNet MarginYoY
-71.70 %-43.84%
-127.66 %-70.80%
-437.14 %+196.06%
-147.65 %+40.13%
-105.37 %+50.27%
-70.12 %-31.80%
-102.81 %+241.01%
-30.15 %-61.59%
-78.49 %-16.78%
-94.31 %-27.15%
-129.45 %-95.61%
-2,948.13 %+81,946.08%
-3.59 %-99.00%
-358.74 %+26,718.18%
-1.34 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

22nd Century Group Stock analysis

What does 22nd Century Group do? 22nd Century Group, Inc. develops biotechnology solutions for tobacco and cannabis plants, focusing on genetic engineering to adjust nicotine levels in tobacco and cannabinoid levels in cannabis. The company creates products like RED SUN and MAGIC cigarettes, which it manufactures, markets, and distributes. It also produces SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA) and offers contract manufacturing for third-party branded tobacco products. The firm's revenue streams include sales of its branded cigarettes, research cigarette production, and contract manufacturing services. The company's primary customers are consumers of its RED SUN and MAGIC cigarette brands, research institutions like NIDA, and third-party tobacco brands seeking contract manufacturing. Its product lines target segments interested in reduced nicotine content for smoking cessation and research purposes. The X-22 smoking cessation aid, featuring very low nicotine (VLN) cigarettes, represents a key product in its portfolio aimed at helping users reduce nicotine dependency. 22nd Century Group's business model revolves around selling its proprietary tobacco products, providing research-grade cigarettes for scientific studies, and fulfilling manufacturing contracts for other brands. The company's focus on genetic engineering for nicotine reduction positions it within the market for less harmful tobacco alternatives, while its contract manufacturing services diversify its revenue sources beyond direct consumer sales. 22nd Century Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 22nd Century Group stock

Net Profit Margin of 22nd Century Group is -71.70 % in 2025.

Net Profit Margin of 22nd Century Group changed from -127.66 % to -71.70 %, representing a -43.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin 22nd Century Group since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's 22nd Century Group with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — 22nd Century Group

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — 22nd Century Group